Mechanistic studies suggest that it binds in a manner similar to amylin, affecting cellular signaling and neuroendocrine pathways
Overview of GLP-1 Receptor Agonists The major GLP-1 receptor agonists available on the market currently are: Dulaglutide (Trulicity) Exenatide extended release (Bydureon BCise) Exenatide (Byetta) Semaglutide (Ozempic, Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) What is Dulaglutide (Trulicity) and its mechanism of action Dulaglutide, sold as Trulicity, is an injectable GLP-1 receptor agonist medication designed for the treatment of type 2 diabetes
Delivery Format: Subcutaneous Injection
GLP-1 agonists are a class of medications that mimic hormones in the body to help regulate blood sugar and appetite
Approximately 25% of the weight lost on tirzepatide was lean mass rather than fat, and in semaglutide trials (STEP 1 DXA subset), that proportion may approach 40%
GCL forms an unusual peptide bond between the -carboxyl of glutamate and the amino group of cysteine using the energy provided by the hydrolysis of ATP (Lu, 2013)